Ovation.io and Illumina launch first-of-kind GLP-1 dataset to accelerate new therapy development

First real-world dataset with integrated clinical and multiomic insights from 25,000 patients treated with GLP-1 therapies

Dataset will advance development of GLP-1 therapies in new indications and accelerate discovery of novel drug targets in patients who are unresponsive to therapies

Read the whole article here:

Read More